FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4285808211> ?p ?o ?g. }

• W4285808211 endingPage "113276" @default.
• W4285808211 startingPage "113276" @default.
• W4285808211 abstract "Chemotherapy resistance limits the efficacy of cisplatin (DDP) when treating non-small cell lung cancer (NSCLC). Circular RNAs (circRNAs) confers a regulatory role in drug resistance. Innovatively, the regulatory role of circular RNA HIPK2 (circHIPK2) in DDP resistance was probed in the work. In this research, tumor tissues and matched normal tissues were obtained from 52 NSCLC patients, and the expressions of circHIPK2, miR-1249-3p and VEGFA in the tissues were detected by qPCR or Western Blot. Correlation analysis of circHIPK2 expression with survival prognosis and clinicopathological features was conducted. Parental NSCLC cell lines (A549, H460) and DDP-resistant cell lines (A549/DDP, H460/DDP) were selected, and the expression of circHIPK2, miR-1249-3p and VEGFA in the cells were detected. Cell IC50 value, proliferation, migration, invasion, apoptosis and angiogenesis were detected. Tumor xenografts were established to detect the role of circHIPK2 in vivo. The binding relationship between circHIPK2, miR-1249-3p and VEGFA was verified by dual luciferase reporter experiment, RNA pull down and RIP experiment. Our data showed that circHIPK2 and VEGFA were abnormally overexpressed and miR-1249-3p was underexpressed in DDP-resistant NSCLC tissues and cell lines. CircHIPK2 knockdown or miR-1249-3p upregulation inhibited DDP resistance, malignant behavior, and angiogenesis in NSCLC. CircHIPK2 by competitive absorption of miR-1249-3p mediated VEGFA. CircHIPK2 promoted the sensitivity of drug-resistant cells to DDP in NSCLC by regulating VEGFA. CircHIPK2 enhanced the growth of DDP-resistant NSCLC cells in vivo. In conclusion, circHIPK2 has the malignant property for angiogenesis and chemoresistance in NSCLC via the network of miR-1249-3p/VEGFA." @default.
• W4285808211 created "2022-07-19" @default.
• W4285808211 creator A5009894408 @default.
• W4285808211 creator A5020585152 @default.
• W4285808211 creator A5037373574 @default.
• W4285808211 creator A5050688244 @default.
• W4285808211 creator A5057615080 @default.
• W4285808211 creator A5062976033 @default.
• W4285808211 creator A5070610406 @default.
• W4285808211 date "2022-10-01" @default.
• W4285808211 modified "2023-10-09" @default.
• W4285808211 title "The malignant property of circHIPK2 for angiogenesis and chemoresistance in non-small cell lung cancer" @default.
• W4285808211 cites W1981486720 @default.
• W4285808211 cites W1995168398 @default.
• W4285808211 cites W2062967876 @default.
• W4285808211 cites W2159515687 @default.
• W4285808211 cites W2515969222 @default.
• W4285808211 cites W2791905050 @default.
• W4285808211 cites W2914178603 @default.
• W4285808211 cites W2927651564 @default.
• W4285808211 cites W2934320411 @default.
• W4285808211 cites W2942134847 @default.
• W4285808211 cites W2944289552 @default.
• W4285808211 cites W2967043226 @default.
• W4285808211 cites W2979465888 @default.
• W4285808211 cites W3011520922 @default.
• W4285808211 cites W3013650706 @default.
• W4285808211 cites W3027157735 @default.
• W4285808211 cites W3036900173 @default.
• W4285808211 cites W3047175868 @default.
• W4285808211 cites W3102129077 @default.
• W4285808211 cites W3108750466 @default.
• W4285808211 cites W3133195764 @default.
• W4285808211 cites W3133798183 @default.
• W4285808211 cites W3161606347 @default.
• W4285808211 cites W3176880007 @default.
• W4285808211 cites W3192784334 @default.
• W4285808211 cites W3210800899 @default.
• W4285808211 doi "https://doi.org/10.1016/j.yexcr.2022.113276" @default.
• W4285808211 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35863454" @default.
• W4285808211 hasPublicationYear "2022" @default.
• W4285808211 type Work @default.
• W4285808211 citedByCount "6" @default.
• W4285808211 countsByYear W42858082112022 @default.
• W4285808211 countsByYear W42858082112023 @default.
• W4285808211 crossrefType "journal-article" @default.
• W4285808211 hasAuthorship W4285808211A5009894408 @default.
• W4285808211 hasAuthorship W4285808211A5020585152 @default.
• W4285808211 hasAuthorship W4285808211A5037373574 @default.
• W4285808211 hasAuthorship W4285808211A5050688244 @default.
• W4285808211 hasAuthorship W4285808211A5057615080 @default.
• W4285808211 hasAuthorship W4285808211A5062976033 @default.
• W4285808211 hasAuthorship W4285808211A5070610406 @default.
• W4285808211 hasConcept C104317684 @default.
• W4285808211 hasConcept C127561419 @default.
• W4285808211 hasConcept C142724271 @default.
• W4285808211 hasConcept C146285616 @default.
• W4285808211 hasConcept C167734588 @default.
• W4285808211 hasConcept C173396325 @default.
• W4285808211 hasConcept C190283241 @default.
• W4285808211 hasConcept C207001950 @default.
• W4285808211 hasConcept C2776256026 @default.
• W4285808211 hasConcept C2776694085 @default.
• W4285808211 hasConcept C2777025900 @default.
• W4285808211 hasConcept C2778239845 @default.
• W4285808211 hasConcept C2780394083 @default.
• W4285808211 hasConcept C502942594 @default.
• W4285808211 hasConcept C54355233 @default.
• W4285808211 hasConcept C62112901 @default.
• W4285808211 hasConcept C71924100 @default.
• W4285808211 hasConcept C81885089 @default.
• W4285808211 hasConcept C86803240 @default.
• W4285808211 hasConceptScore W4285808211C104317684 @default.
• W4285808211 hasConceptScore W4285808211C127561419 @default.
• W4285808211 hasConceptScore W4285808211C142724271 @default.
• W4285808211 hasConceptScore W4285808211C146285616 @default.
• W4285808211 hasConceptScore W4285808211C167734588 @default.
• W4285808211 hasConceptScore W4285808211C173396325 @default.
• W4285808211 hasConceptScore W4285808211C190283241 @default.
• W4285808211 hasConceptScore W4285808211C207001950 @default.
• W4285808211 hasConceptScore W4285808211C2776256026 @default.
• W4285808211 hasConceptScore W4285808211C2776694085 @default.
• W4285808211 hasConceptScore W4285808211C2777025900 @default.
• W4285808211 hasConceptScore W4285808211C2778239845 @default.
• W4285808211 hasConceptScore W4285808211C2780394083 @default.
• W4285808211 hasConceptScore W4285808211C502942594 @default.
• W4285808211 hasConceptScore W4285808211C54355233 @default.
• W4285808211 hasConceptScore W4285808211C62112901 @default.
• W4285808211 hasConceptScore W4285808211C71924100 @default.
• W4285808211 hasConceptScore W4285808211C81885089 @default.
• W4285808211 hasConceptScore W4285808211C86803240 @default.
• W4285808211 hasIssue "2" @default.
• W4285808211 hasLocation W42858082111 @default.
• W4285808211 hasLocation W42858082112 @default.
• W4285808211 hasOpenAccess W4285808211 @default.
• W4285808211 hasPrimaryLocation W42858082111 @default.
• W4285808211 hasRelatedWork W2033057666 @default.
• W4285808211 hasRelatedWork W2052861245 @default.

• next